UK medtech sector boosted by launch of Anglia Ruskin MedTech Campus
22 May 2012
A groundbreaking partnership to drive growth and innovation in
the UK medical technology sector was launched at the House of Commons
The Anglia Ruskin MedTech Campus will provide one of the
world’s largest health innovation spaces, with the aim of
establishing the UK as a global force in a sector worth over £170
billion per year.
Specialising in near-market solutions for products and services,
this cluster of expertise in eastern England will be of enormous
benefit to healthcare providers and commissioners. The Anglia Ruskin
MedTech Campus has already secured support from a number of key
stakeholders in industry, local and central government and the NHS.
The partnership was formally launched at the House of Commons by
Parliamentary Under Secretary of State in the Department of Health
Earl Howe, along with representatives of Anglia Ruskin University,
Southend University Hospital and three local councils from Essex.
Earl Howe said, "I am delighted to add my support to this
extremely exciting adventure. Since I took over a couple of years
ago as minister with responsibility for innovation in the NHS I have
been more than ever aware of how rich a history we have in this
country of innovative new ideas stretching back to the industrial
revolution. We also have in the NHS the world's largest and longest
established national system for healthcare.
"These two facts about our past make a powerful statement about
what our future could be. In the more than six decades of the NHS,
in partnership with the UK's top universities, we've been at the
forefront in advances of medical sciences yet we've sometimes been a
lot less successful in translating these discoveries into widely
adopted products and services.
"Instead it has often been our competitors who have profited from
our ingenuity. This has partly been because of a lack appropriate
infrastructure. All too often the necessary components all medical
innovation are not located in the same place. So we have got all the
right talents in the UK, we just need to harvest them.
"The med tech campus I think is the first of its kind in this
country, and represents a real boost for innovation. It supports us
in our quest to continue as a world leader in medical innovation. It
provides a springboard for economic growth and development in the
UK. I would like to congratulate all the partners who had the vision
and the drive to establish this venture and wish it every success."
Partnership for medtech development
The project, which is a partnership between Chelmsford City
Council, Harlow District Council, Southend-on-Sea Borough Council
and Anglia Ruskin University, is predicted to grow the UK medical
technology sector by £1.2bn and generate approximately 12,500 jobs.
Anglia Ruskin is the lead academic partner and key provider of
business and innovation services. It will facilitate access to a
range of relevant expertise, sector-dedicated research, specialist
consultancy staff, and testing and clinical trials capabilities. The
local authorities will use their land use, economic development and
community well-being powers to engage the development industry and
attract inward investment.
Three sites will be developed across Essex — in Chelmsford,
Harlow and Southend-on-Sea — and 120 acres of land has already been
identified to accommodate the 1.7 million square feet of floor
space. A business network will act as a catalyst for innovation,
supporting the commercial exploitation of ideas through a portfolio
of services offered domestically and internationally.
(back row, left
to right): Rob Tinlin (Southend-on-Sea Borough Council Chief
Executive), Daniel Coole (Managing Director of Surgical
Holdings), Lord Tomlinson (Chair of the Board of Governors
at Anglia Ruskin University) and Tony Young (Consultant
Urological Surgeon at Southend University Hospital and
Director of Medical Innovation at Anglia Ruskin University).
(Front row, left to right): Steve Packham
(Chelmsford City Council Chief Executive), Professor Michael
Thorne (Anglia Ruskin University’s Vice Chancellor), Earl
Howe (Parliamentary Under Secretary of State in the
Department of Health), Sir Duncan Nichol (Non-Executive
Director of Synergy Health plc) and Malcolm Morley (Harlow
District Council Chief Executive).
Harlow Council Chief Executive, Malcolm Morley, said: “Harlow is
a centre of innovation and has recently gained Enterprise Zone
status focusing on medical technology, advanced manufacturing and
ICT. The Anglia Ruskin MedTech Campus is a great fit with the
Enterprise Zone and the aspirations of the town, and it will
leverage the town’s comparative advantages.”
Steve Packham, Chelmsford City Council’s Chief Executive, said:
“Chelmsford has long been a centre for economic growth, further
enhanced this year by the granting of city status. Our long-standing
partnership arrangements with organisations throughout the area have
led to our engagement and support of the Anglia Ruskin MedTech
Campus; a project that presents an exciting and outstanding
opportunity on a global scale.”
Southend-on-Sea Borough Council Chief Executive, Rob Tinlin,
said: “We already enjoy an important medical technology cluster in
the borough with global names such as Olympus Keymed located here,
and the Anglia Ruskin MedTech Campus will create opportunities for
innovators to exploit their potential, businesses to work together
in a way they haven’t before and for new health solutions to be
developed improving quality of life for residents. Together this
will create jobs and increase learning opportunities.”
As well as delivering a major economic boost for the UK, and
Essex in particular, the Anglia Ruskin MedTech Campus will lead to
community and patient benefits through the adoption of improved
health products and services. Anglia Ruskin University is home to
the Postgraduate Medical Institute — a research centre actively
supported by 22 regional health and social care partners — and over
30,000 students, 8,000 of whom are studying subjects relevant to the
medical technology sector.
Professor Michael Thorne, Anglia Ruskin’s Vice Chancellor, said:
“Our vision for the Anglia Ruskin MedTech Campus is as a globally
leading centre for medical innovation, building on our world-leading
research in subjects allied to medicine and the solid partnerships
we have built up over the years with the healthcare sector and with
Anglia Rusking MedTech Campus: